FluoSphera

🚀 New Episode Alert! 🚀 FluoSphera & Spirochrome: Episode 2 🎥 We are thrilled to share the next chapter in our series with Spirochrome! In this episode, we demonstrate the selective binding of trastuzumab within co-cultured cancer spheroids, combined with the precision of PKmem probes. Our real-time imaging over five hours beautifully captures the progressive binding of trastuzumab-FITC to targeted cancer cells. 🧪 This experiment represents a major milestone in leveraging multiplexed 3D cell culture systems for oncology research. It allows us to closely mimic and study the complexities of tumor microenvironments, pushing us closer to transforming drug discovery with greater precision and confidence. Spirochrome’s advanced probes demonstrate their exceptional compatibility with our systems, enabling unmatched observation and insights into cellular processes. Congratulations to our incredible team and partners for making this achievement a reality! 💡 Stay tuned for Episode 3! 🎬 #Oncology #3DCellCulture #DrugDiscovery #FluoSphera #Innovation #Biotech #Spirochrome #PKmem #ACCESSGeneva

Don't miss the kiosk and the presentation of FluoSphera today at the iGEM 2024! 🚀

🚀FluoSphera will be at the iGEM 2024 Grand Jamboree in Paris, the worldwide competition in synthetic biology (aka #SynBio)! Don't miss the panel "Transforming Healthcare: innovations at the intersection of Medicine and Technology" (page 4 below 👇) A panel of leading experts, including our CSO Gregory Segala, will be invited to share their thoughts on cutting-edge solutions improving patient outcomes and shaping the future of #healthcare. Jonty Corrin Gavin Yirajen VUDDAMALAY, PhD Nina Aune-Youssoufou Moderated by: Alya M. Many thanks iGEM Startups for organizing this discussion and for the invitation in the panel!

🌟 FluoSphera at the Festival of Biologics! 🌟 We're delighted to announce that FluoSphera will be attending the Festival of Biologics from 15th-17th October 2024! Come meet Gregory Segala and Clelia Bourgoint to learn more about FluoSphera's cutting-edge technology and discuss meaningful projects of NBE co-development with an unprecedented human relevance. 🚀 #FestivalOfBiologics #Biotech #Innovation #Oncology #DrugDiscovery #Biologics2024 #NBE #ADC #antibody

💥 Explosive News! FluoSphera & Spirochrome: Episode 1 🎥 At FluoSphera, we are thrilled to integrate the innovative PKmem probes from Spirochrome into our encapsulated cancer spheroids, taking our tissue color-coding palette to a whole new level. The result is astonishing—like spheroid supernovas! 🌟 Spirochrome’s advanced probes offer exceptional compatibility with our systems, allowing for precise visualization 🔬 for over 72 hours, without any toxicity or photobleaching, ensuring optimal observation of cellular processes. With the PKmem probes, we achieve improved imaging quality 📈 and deeper insights into the dynamic interactions within our 3D cultures, pushing the boundaries of what's possible in drug discovery. Stay tuned for Episode 2 next week! 🎬 #drugdiscovery #fluorescence #microscopy #cellculture #spheroids #3d #imaging #bioimaging #confocal #collaboration #partnership #cancer #oncology

🌟 Great News!🌟 FluoSphera, an iGEM Alumni spin-off (iGEM Geneva 2019), has placed 39th in the Top 100 Swiss Startup Ranking for 2024! 🎉 💡Co-founded by Gregory Segala, Clélia Bourgoint, and Aurélien Roux, FluoSphera is revolutionizing drug discovery with innovative high-throughput and systemic solutions that reduce costs and boost efficiency. 🧪💰Earlier this year, they secured a CHF 1.1 million grant from Innosuisse. We’re thrilled to see them at the BioInnovation Fair this year! 🎤 Meet FluoSphera at the iGEM Grand Jamboree, happening from October 23-26, 2024! 🎫Get your jamboree ticket now - jamboree.igem.org #igem #igemstartups #synbio #Biofounders #bioentrepreneurship #igem2024

🚀 EXCITING NEWS! 🚀 We’re thrilled to announce a collaboration between FluoSphera and Spirochrome! 🎉 Together, we’re leveraging FluoSphera’s unique technology platform and Spirochrome’s innovative live-cell probes to push the boundaries of cancer research - starting with breast cancer models. This collaboration focuses on advanced cell imaging and the use of Antibody-Drug Conjugates (ADC) to bring a new vision to drug discovery. 💡🔬 Stay tuned as we release a series of posts exploring how these cutting-edge innovations could transform the field of oncology. More exciting updates to come! 👩🔬👨🔬✨ #Biotech #Innovation #CancerResearch #Partnership #CellImaging #Probes #ADC #FluoSphera #Spirochrome #ScienceForTomorrow

Exciting news! 🚀 FluoSphera will be attending the Drug Discovery Conference 2024 - ELRIG UK in London next week! We’re thrilled to showcase our cutting-edge drug discovery platform designed to revolutionize the way drug efficacy and toxicity are assessed. 🧬 At FluoSphera, we propel drug testing into a new dimension by delivering human-relevant, systemic, and predictive data—well before a drug reaches the first patient. 🧪✨ This is an incredible opportunity to meet with industry leaders, discuss the future of drug discovery, and explore partnership opportunities, notably with developers of Antibody-Drug Conjugates (#ADC) and small molecules. Whether you’re interested in groundbreaking technologies, collaborative ventures, or simply networking with like-minded innovators, let’s connect and discuss how we can advance the future of drug therapy together! 🔬💡🤝 Looking forward to seeing you there! 👋 #DrugDiscovery #ELRIG2024 #Innovation #LifeSciences #Networking #Collaboration #London #Therapy

#RESIBoston was an incredible event! 🚀 It was a great opportunity to present FluoSphera to a jury that showed curiosity and openness towards disruptive technologies. 💡 Throughout the partnering sessions and at our booth, we formed many new and valuable connections. 🤝 The discussions touched on key topics such as the current state of life science investments 💸, the opportunities and challenges of fundraising, deal-making, and building and leading teams. ✨Fun fact: Our booth neighbor, Michael Lukesch, CEO of VALANX Biotech, is also a fellow IndieBio alum. 🎓 What a small world! 🌍 #RESIBoston #LifeScience #Innovation #Networking #Fundraising #RESIBoston IndieBio Life Science Nation